Company intelligence / Profile preview

OM BIOMEDIC

Haridwar, Uttarakhand, Indiaombiomedic.com ↗

Ownership: Private
Development stage: Commercial

Overview

OM BIOMEDIC is an active Indian pharmaceutical company manufacturing over 1000 generic medicines in various dosage forms. Its portfolio includes antibiotics such as colistimethate sodium and meropenem; NSAIDs like aceclofenac; analgesics such as acetaminophen; vitamin supplements like mecobalamin; and other essential drugs. The company is WHO-GMP certified and supplies both domestic and international markets.

Therapeutic areas: OtherRheumatologyNeurologyInfectious Diseases
Modalities: Small moleculeAntibiotic (as a class of small molecules)Vitamin supplement (as a class of small molecules)
Industry: Biotech

Beyond the preview

Go deeper on OM BIOMEDIC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OM BIOMEDIC.

Explore the full profile